Renal Function and Direct Oral Anticoagulant Treatment for Venous Thromboembolism

John Fanikos, Allison E. Burnett, Charles E. Mahan, Paul P. Dobesh

Research output: Contribution to journalReview article

2 Scopus citations

Abstract

Because differences in renal function can affect the efficacy and safety of direct oral anticoagulants, prescribing an appropriate dose based on renal function is critical, especially in patient populations with a high incidence of renal impairment. In patients with nonvalvular atrial fibrillation and mild or moderate renal impairment, direct oral anticoagulants are associated with a better risk–benefit profile compared with warfarin. However, less is known regarding outcomes in patients with venous thromboembolism and renal impairment. The efficacy and safety of direct oral anticoagulants in patients with venous thromboembolism and renal impairment are primarily derived from prespecified subgroup analyses of the phase 3 clinical trials. We summarize the available data on direct oral anticoagulant use in patients with venous thromboembolism and renal impairment. Clinicians are encouraged to follow study inclusion/exclusion criteria and perform renal dose adjustments based on the Cockcroft–Gault equation using actual body weight when indicated to avoid adverse events.

Original languageEnglish (US)
Pages (from-to)1137-1143
Number of pages7
JournalAmerican Journal of Medicine
Volume130
Issue number10
DOIs
StatePublished - Oct 2017

Keywords

  • Direct oral anticoagulants
  • Renal
  • Venous thromboembolism

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Renal Function and Direct Oral Anticoagulant Treatment for Venous Thromboembolism'. Together they form a unique fingerprint.

  • Cite this